Searched for
VOVERAN
Novartis exits India arm, ChrysCapital-led group buys 70.68% stake for ₹1,446 croreSwiss drugmaker Novartis AG is selling its 70.68% stake in its Indian unit for Rs 1,446 crore to a consortium led by ChrysCapital. This div...- Novartis India shares soar 20% as Swiss parent plans full exit in Rs 1,446 crore dealNovartis India shares surged nearly 18% after its Swiss parent announced the sale of its 70.68% stake for approximately Rs 1,446 crore. A c...
- Dr Reddy's inks exclusive sales pact with Novartis IndiaUnder the arrangement, Dr Reddy's will have exclusive rights to promote and distribute the well-established Voveran range, the Calcium rang...
- Novartis India enters distribution pact with DRL for top brands, to lay off 400 employeesNovartis India said its strategic business decision will lead to the separation of approximately 400 employees due to role redundancies.
- Indian pharma company may sue drug controller over safety of Novartis painkillerNovartis’ Voveran 1ml and Themis' Aquadol have competed with Troikaa’s own injection to manage pain, Dynapar AQ, since their launch in 2013.
- Delhi government bans over the counter sale of NSAIDS without prescriptionDelhi govt banned over-the-counter sale of non-steroidal anti-inflammatory drugs like Aspirin, Dispirin, Brufen, Voveran, without medical p...
- Novartis Q2 Net down 69 per cent; transfers animal health businessNet sales, however, rose to Rs 227.83 crore for the second quarter, as against Rs 209.18 crore for the same period of previous fiscal
- Heritage brands like Combiflam, Liv-52, Benadryl and others big earners in pharmaDrugs launched over 20 yrs ago remain money-spinners in the Indian pharma mkt because of strong brand recall and better access in smaller c...
- Retail sales of medicines grew 8.9% in JulyRetail sales of medicines grew 8.9% in July over the year ago period, down from 18.3% in the month of June, due to deficient monsoon.
- Drug sales rise 18% to Rs 3,230 crRetail sales of medicine in the domestic market grew by 18.3% to Rs 3,230 crore in June as dealers and retailers increased stockpiles to pr...
- Pharma cos’ sales jump 10% in MayPharma companies have recorded robust sales in May 2009, as per ORG IMS data, with a moving annual total (MAT) of 10.4% at Rs 36,048 crore ...
- Medicine sales rise by 10%Sale of medicines to consumers grew 9.8% to Rs 34,000 crore in the calender year 2008, compared with 13.4% in 2007.
- Piramal's cough syrup top-selling drug in JunePiramal Healthcare’s cough syrup Phensedyl has toppled Swiss drug major Novartis’s pain killer brand Voveran to emerge as the country’s lar...
- Pharma companies going slow on drug launchesIn what is seen as a fallout of the product patent regime, drug makers are launching lesser number of brands in the Rs 33,000-crore domesti...
- Voveran pips Corex to emerge best sellerNovartis’ painkiller, Voveran, has emerged as the best-selling drug in the country.
- Cipla beats Ranbaxy, tops sales in SeptemberCipla's sales grew 15.3% from last month, garnering 4.92% while Ranbaxy sales grew just 0.9% with a mkt share of 4.81%. Drug cos in price w...
- Ayurvedic brand Liv-52, India's top selling drugFor a sales index that’s perpetually skewed towards cough syrups, which is often misused as a cheap substitute for alcohol, and pain killer...
- Pfizer, Nicholas Piramal hit by codeine shortageHit by the shortage of raw material codeine, India’s highest selling drug (in value) Pfizer’s cough syrup Corex has slipped to the eighth s...
- It's advantage consumers as top drug brands face price cutConsumers using blockbuster drug brands are set to benefit more from the government’s proposed drug pricing formula.
- Petroleum prices could decline in coming weeksPetroleum prices could head downward in the coming few weeks if global crude rates decline further, the government today said.
Load More
